CIMEIO THERAPEUTICS
Cimeio Therapeutics develops curative treatments for genetic diseases, hematologic malignancies, and severe autoimmune disorders.
CIMEIO THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2020-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.cimeio.com
Total Employee:
11+
Status:
Active
Contact:
+41 61 577 2316
Email Addresses:
[email protected]
Total Funding:
50 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Global Site Tag Mobile Non Scaleable Content Organization Schema Google Maps
Current Advisors List
Investors List
Versant Ventures
Versant Ventures investment in Series A - Cimeio Therapeutics
Official Site Inspections
http://www.cimeio.com
- Host name: ip72.ip-51-77-75.eu
- IP address: 51.77.75.72
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Cimeio Therapeutics"
About Us - Cimeio Therapeutics
Cimeio is a therapeutics company developing Shielded-Cell & Immunotherapy Pairs™ (SCIP), novel immunotherapies which have the potential to transform treatment of hematologic …See details»
Cimeio Therapeutics - Crunchbase Company Profile
Cimeio Therapeutics develops curative treatments for genetic diseases, hematologic malignancies, and severe autoimmune disorders.See details»
Cimeio Therapeutics 2025 Company Profile: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Cimeio Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Cimeio Therapeutics AG - RIDGELINE Discovery
Cimeio Therapeutics is an applied gene editing, cellular, and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairs (tm) for patients with debilitating and life …See details»
Cimeio Company Profile - Office Locations, Competitors, Revenue …
Cimeio has 5 employees at their 1 location and $50 m in total funding,. See insights on Cimeio including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Cimeio Therapeutics - Funding, Financials, Valuation & Investors
Cimeio Therapeutics develops curative treatments for genetic diseases, hematologic malignancies, and severe autoimmune disorders.See details»
Cimeio Therapeutics - Overview, News & Similar companies
Dec 11, 2023 View Cimeio Therapeutics (www.cimeio.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Cimeio Therapeutics - VentureRadar
"Cimeio is an applied gene editing and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairs™ (SCIP), which has the potential to transform …See details»
Cimeio Therapeutics AG (Cimeio Therapeutics AG) - 药 …
About Cimeio Therapeutics Cimeio is an immunotherapy company developing Shielded-Cell & Immunotherapy Pairs™ (SCIP), novel immunotherapies which have the potential to transform treatment of hematologic diseases. Cimeio …See details»
Cimeio Therapeutics (USA) Funding: $50M - medicalstartups.org
Feb 20, 2025 Cimeio Therapeutics is applied gene editing, cellular and immunotherapy company, developing shielded-cell and immunotherapy pairs to transform treatment for rare …See details»
Privacy Statement (CA) - Cimeio Therapeutics
We have appointed a contact person for the organization’s policies and practices and to whom complaints or inquiries can be forwarded: Thomas Fuchs Cimeio Therapeutics, Inc. 1 …See details»
Company: Cimeio Therapeutics - CRISPR Medicine
Cimeio is an applied gene-editing and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairs™ (SCIP), which has the potential to transform …See details»
Cimeio Therapeutics AG - Swiss Biotech
Founded in 1998, the Swiss Biotech Association represents the interests of the Swiss biotech industry. To support its members, the association works to secure favorable framework …See details»
Cimeio Therapeutics Company Information - Funding, Investors, …
Get information on funding, investors, industries, and more for Cimeio Therapeutics. See Cimeio Therapeutics company profile and funding data.See details»
$50 Million Series A - versantventures.com
Today, Versant Ventures announced the debut of Cimeio Therapeutics, a biotechnology company developing a novel approach to cell therapies. Versant has made a $50 million Series A …See details»
Cimeio exits stealth with $50M, but its cell therapy technology …
Apr 13, 2022 Novel cell therapy company Cimeio Therapeutics is exiting stealth mode—though its science isn’t. The Versant Ventures-backed company has publicly entered the industry with …See details»
Cimeio Therapeutics receives USD 50 million to advance new …
Apr 13, 2022 Versant Ventures has made a $50 million Series A commitment to Cimeio, which is the most recent start-up to emerge from the firm’s Ridgeline Discovery Engine in Basel, …See details»
News - Cimeio Therapeutics
Dec 9, 2024 Get the latest news regarding Cimeio Therapeutics, an applied gene editing and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairs™ …See details»
CMO + CIO = CG&IO? AI Is Forcing Us To Embrace Shared
9 hours ago According to the 2024 Gartner AI Survey, 57% of CIOs said that they are now responsible for leading their organization’s AI strategy to bring holistic governance over data, …See details»
Tom Home Page - Cimeio Therapeutics
Mar 29, 2022 Our platform represents a fundamentally new approach to immunotherapy. Our therapies have the potential to offer a cure for patients with the most difficult to treat …See details»